期刊文献+
共找到4篇文章
< 1 >
每页显示 20 50 100
miR-34a抑制BCL-2激活NLRP1炎症小体诱导大鼠癫痫的发生 被引量:1
1
作者 高玉广 马玉娟 +3 位作者 莫穷泽 廖煜雄 刘琦琦 何乾超 《海南医学院学报》 CAS 2023年第1期15-22,共8页
目的:探究miR-34a影响癫痫的相关机制。方法:通过MicroRNA微阵列芯片和RT-PCR分析miR-34a在癫痫大鼠中的表达量,并观察miR-34a与癫痫发作频率和脑电图的关系;预测miR-34a的靶基因,采用双荧光素酶报告基因实验观察其与靶基因的结合情况,... 目的:探究miR-34a影响癫痫的相关机制。方法:通过MicroRNA微阵列芯片和RT-PCR分析miR-34a在癫痫大鼠中的表达量,并观察miR-34a与癫痫发作频率和脑电图的关系;预测miR-34a的靶基因,采用双荧光素酶报告基因实验观察其与靶基因的结合情况,观察过表达和抑制miR-34a对靶基因的影响,随后过表达和抑制靶基因,观察其对下游因子的影响,最终探究miR-34a影响癫痫的相关机制。结果:微阵列芯片和RT-PCR检测表明miR-34a在癫痫中呈高表达(P<0.05),miR-34a表达水平与癫痫发作频率呈正相关(R=0.783,P=0.003),抑制miR-34a的表达可明显减少癫痫的发作频率(P<0.05)。在线数据库TargetScan和miRDB显示miR-34a与BCL-2具有结合区域,双荧光素酶报告基因实验证明两者具有结合关系,当miR-34a过表达时,BCL-2表达量会下调,相反,当miR-34a抑制时,BCL-2表达量会上调。癫痫大鼠脑组织中NLRP1及下游相关因子Caspase-3、Caspase-1、IL-1β、IL-18高表达(P<0.05),当BCL-2抑制时,NLRP1及下游的相关因子表达量会更高,当BCL-2抑制时,结果则相反。结论:高表达的miR-34a通过抑制BCL-2,活化NLRP1炎症小体从而诱发癫痫发生。 展开更多
关键词 癫痫 MIR-34A BCL-2 NLRP1炎症小体
下载PDF
miR-34a inhibits BCL-2 activation of the NLRP1 inflammasomeinduced epilepsy in mice
2
作者 GAO Yu-guang MA Yu-juan +3 位作者 MO Qiong-ze liao yu-xiong LIU Qi-qi HE Qian-chao 《Journal of Hainan Medical University》 2023年第1期14-20,共7页
Objective:To explore the related mechanism of miR-34a affecting epilepsy.Methods:MicroRNA microarray chip and RT-PCR were used to analyze the expression of miR-34a in epileptic rats,and observe the relationship betwee... Objective:To explore the related mechanism of miR-34a affecting epilepsy.Methods:MicroRNA microarray chip and RT-PCR were used to analyze the expression of miR-34a in epileptic rats,and observe the relationship between miR-34a and seizure frequency and EEG.Predicted the target gene of miR-34a,used The dual-luciferase reporter gene assay was used to observe its binding to the target gene of miR-34a,the effect of overexpression and inhibition of miR-34a on the target gene,the effects of overexpression and inhibition of target genes on downstream factors.Results:Microarray chip and RT-PCR detection showed that miR-34a was highly expressed in epilepsy(P<0.05),and miR-34a was positively correlated with seizure frequency(R=0.783,P=0.003),and inhibition of miR-34a inhibited the seizure frequency of epilepsy(P<0.05).The online databases TargetScan and miRDB show that miR-34a and BCL-2 have a predicted binding region,and the dual-luciferase reporter gene experiment proves that the two have a binding relationship.When miR-34a was overexpressed,BCL-2 expression was down-regulated,and conversely,when miR-34a was inhibited,BCL-2 expression was up-regulated.NLRP1 and downstream related factors Caspase-3,Caspase-1,IL-1βand IL-18 were highly expressed in the brain tissue of epileptic rats(P<0.05).When BCL-2 was inhibited,the expression levels of NLRP1 and downstream related factors were increased,and when BCL-2 was inhibited,the result was the opposite.Conclusion:The highly expressed miR-34a promotes epilepsy by inhibiting BCL-2 and activating the NLRP1 inflammasome. 展开更多
关键词 EPILEPSY MIR-34A BCL-2 NLRP1 inflammasome
下载PDF
小柴胡汤联合认知行为疗法对躯体形式障碍的疗效相关因素分析 被引量:11
3
作者 莫穷泽 何乾超 +7 位作者 高玉广 邓惠 庞东林 刘永辉 刘琦琦 廖煜雄 马玉娟 黄丽蓉 《安徽中医药大学学报》 CAS 2021年第4期36-40,共5页
目的探讨影响小柴胡汤联合心理干预对躯体形式障碍(somatoform disorders,SFD)患者的疗效相关因素。方法采用单盲抽样法,选取广西中医药大学第一附属医院脑病科门诊及住院部的SFD患者为研究对象,将SFD患者的年龄、依从性、躯体形式障碍... 目的探讨影响小柴胡汤联合心理干预对躯体形式障碍(somatoform disorders,SFD)患者的疗效相关因素。方法采用单盲抽样法,选取广西中医药大学第一附属医院脑病科门诊及住院部的SFD患者为研究对象,将SFD患者的年龄、依从性、躯体形式障碍程度、疗程、心理干预频率、病程、职业、中医证型、治疗方式等资料进行赋值,采用Logistic回归分析法进行相关因素分析。结果单因素分析表明,SFD患者的年龄、依从性、病程、躯体形式障碍严重程度、疗程、心理干预频率、中医证型、治疗方式与疗效存在相关性(P<0.05);Logistic回归分析显示,躯体障碍程度是影响小柴胡汤联合认知行为疗法治疗SFD患者疗效的最大因素(OR=5.675,P<0.05)。结论小柴胡汤联合认知行为疗法治疗躯体形式障碍有效,同时应关注影响疗效的相关因素,有助于提高疗效。 展开更多
关键词 躯体形式障碍 小柴胡汤 认知行为疗法 相关因素
下载PDF
Research progress on the mechanism of TCM treatment of depression based on NLRP3 pathway
4
作者 LIU Qi-qi HE Qian-chao +3 位作者 LIU Yong-hui GAO Yu-guang MO Qiong-ze liao yu-xiong 《Journal of Hainan Medical University》 2022年第18期70-74,共5页
To review the research progress on the mechanism of traditional Chinese medicine(TCM)treatment of depression based on NLRP3 pathway in the past five years,in order to provide the basis for the clinical application of ... To review the research progress on the mechanism of traditional Chinese medicine(TCM)treatment of depression based on NLRP3 pathway in the past five years,in order to provide the basis for the clinical application of TCM treatment of depression.NLRP3,TCM and depression were used as key words to search PubMed and China Journal Fulltext Database(CNKI)and other databases for the relevant experimental literatures on antidepressant effects of TCM based on NLRP3 pathway in recent years.Chinese medicine can protect nerve cells by inhibiting the activation of NLRP3 and reduce the depression-like behavior in animal model.TCM can inhibit NLRP3 pathway and exert anti-depressive effect. 展开更多
关键词 NLRP3 Traditional Chinese medicine DEPRESSION REVIEW
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部